Search details
1.
Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
Emerg Infect Dis
; 30(3): 568-571, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38407158
2.
Drug-resistant tuberculosis: advances in diagnosis and management.
Curr Opin Pulm Med
; 28(3): 211-217, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35220372
3.
Enhanced active case finding of drug-resistant tuberculosis in Namibia: a protocol for the hotspots, hospitals, and households (H3TB) study.
BMJ Open
; 14(2): e082665, 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-38341211
4.
Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis.
Lancet Infect Dis
; 2024 Mar 12.
Article
in English
| MEDLINE | ID: mdl-38490237
5.
Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys: Time for household-wide interventions?
PLOS Glob Public Health
; 4(2): e0002596, 2024.
Article
in English
| MEDLINE | ID: mdl-38422092
6.
Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes.
Front Public Health
; 11: 1204064, 2023.
Article
in English
| MEDLINE | ID: mdl-37674674
7.
Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys.
EClinicalMedicine
; 63: 102191, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37680950
8.
Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review.
JMIR Res Protoc
; 11(12): e40009, 2022 Dec 15.
Article
in English
| MEDLINE | ID: mdl-36520530
9.
Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia.
ERJ Open Res
; 6(1)2020 Jan.
Article
in English
| MEDLINE | ID: mdl-32201689
10.
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
Patient Prefer Adherence
; 10: 2369-2377, 2016.
Article
in English
| MEDLINE | ID: mdl-27920503
11.
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
BMC Pharmacol Toxicol
; 16: 36, 2015 Dec 10.
Article
in English
| MEDLINE | ID: mdl-26654443
12.
Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study.
J Pharm Policy Pract
; 7(1): 14, 2014.
Article
in English
| MEDLINE | ID: mdl-25383192
13.
Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
Drug Saf
; 36(11): 1087-96, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-23917883
14.
The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia.
South Med Rev
; 5(1): 6-13, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-23093894
Results
1 -
14
de 14
1
Next >
>>